Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Meritage Homes
MTH
KB Home
KBH
D.R. Horton
DHI
US Stock MarketDetailed Quotes
ACLX Arcellx
- 76.690
- -1.660-2.12%
Close Dec 31 16:00 ET
- 76.690
- 0.0000.00%
Post 20:01 ET
4.15BMarket Cap-108.01P/E (TTM)
80.000High75.960Low404.39KVolume79.430Open78.350Pre Close31.29MTurnover1.26%Turnover RatioLossP/E (Static)54.07MShares107.37052wk High8.59P/B2.46BFloat Cap47.88052wk Low--Dividend TTM32.03MShs Float107.370Historical High--Div YieldTTM5.16%Amplitude6.035Historical Low77.374Avg Price1Lot Size
About Arcellx Company
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolACLX
Company NameArcellx
Listing DateFeb 4, 2022
Issue Price15.00
Founded2014
CEOMr. Rami Elghandour
MarketNASDAQ
Employees130
Fiscal Year Ends12-31
Address25 West Watkins Mill Road,Suite A
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20878
Phone1-240-327-0603
Websitehttp://www.arcellx.com
Company Executives
- Name
- Position
- Salary
- Rami Elghandour
- President, Chief Executive Officer and Chairman of the Board
- 24.96M
- Dr. Christopher Heery, M.D.
- Chief Medical Officer
- 3.86M
- Michelle Gilson
- Chief Financial Officer and Principal Accounting Officer
- 3.55M
- Jill Carroll, M.S.
- Independent Director
- 353.67K
- Dr. Kavita K. Patel, M.D.
- Independent Director
- 344.67K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 355.17K
- David Charles Lubner, C.P.A.,M.S.
- Independent Director
- 359.67K
- Olivia C. Ware, M.B.A.
- Independent Director
- 343.67K
- Derek Yoon
- Independent Director
- 347.17K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.